Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Win 400 14
1. 62265-68-3
2. Amenide
3. Amenox
4. Win 40014
5. Quinfamido
6. 1-(dichloroacetyl)-6-(2-furoyloxy)-1,2,3,4-tetrahydroquinoline
7. Win-40014
8. 2-furancarboxylic Acid, 1-(dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinyl Ester
9. 2-furancarboxylic Acid, 1-(2,2-dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinyl Ester
10. O1zb1046r1
11. [1-(2,2-dichloroacetyl)-3,4-dihydro-2h-quinolin-6-yl] Furan-2-carboxylate
12. Quinfamidum
13. Quinfamide [usan:inn]
14. Quinfamidum [inn-latin]
15. Quinfamido [inn-spanish]
16. Einecs 263-478-1
17. Brn 1554485
18. Quinfamida
19. Unii-o1zb1046r1
20. Amenide (tn)
21. Quinfamide [mi]
22. Quinfamide [inn]
23. Quinfamide (usan/inn)
24. Quinfamide [usan]
25. 2-furoic Acid Ester With 1-(dichloroacetyl)-1,2,3,4-tetrahydro-6-quinolinol
26. Quinfamide [mart.]
27. Quinfamide [who-dd]
28. Schembl635943
29. Chembl2107014
30. Dtxsid90211320
31. Chebi:135493
32. Zinc538272
33. Amy23418
34. Bcp10697
35. Ex-a3370
36. Mfcd00864662
37. Akos030227997
38. Db12780
39. As-73999
40. Hy-119826
41. Cs-0078079
42. Ft-0674272
43. D00641
44. 265q683
45. A833687
46. Q21098930
47. 1-(2,2-dichloroacetyl)-1,2,3,4-tetrahydroquinolin-6-yl Furan-2-carboxylate
Molecular Weight | 354.2 g/mol |
---|---|
Molecular Formula | C16H13Cl2NO4 |
XLogP3 | 3.8 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 353.0221633 g/mol |
Monoisotopic Mass | 353.0221633 g/mol |
Topological Polar Surface Area | 59.8 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 459 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
ABOUT THIS PAGE
A Quinfamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Quinfamide, including repackagers and relabelers. The FDA regulates Quinfamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Quinfamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Quinfamide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Quinfamide supplier is an individual or a company that provides Quinfamide active pharmaceutical ingredient (API) or Quinfamide finished formulations upon request. The Quinfamide suppliers may include Quinfamide API manufacturers, exporters, distributors and traders.
click here to find a list of Quinfamide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Quinfamide written confirmation (Quinfamide WC) is an official document issued by a regulatory agency to a Quinfamide manufacturer, verifying that the manufacturing facility of a Quinfamide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Quinfamide APIs or Quinfamide finished pharmaceutical products to another nation, regulatory agencies frequently require a Quinfamide WC (written confirmation) as part of the regulatory process.
click here to find a list of Quinfamide suppliers with Written Confirmation (WC) on PharmaCompass.
Quinfamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Quinfamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Quinfamide GMP manufacturer or Quinfamide GMP API supplier for your needs.
A Quinfamide CoA (Certificate of Analysis) is a formal document that attests to Quinfamide's compliance with Quinfamide specifications and serves as a tool for batch-level quality control.
Quinfamide CoA mostly includes findings from lab analyses of a specific batch. For each Quinfamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Quinfamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Quinfamide EP), Quinfamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Quinfamide USP).
LOOKING FOR A SUPPLIER?